fibrinogen has been researched along with Polycystic Ovary Syndrome in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 8 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Huang, K; Shi, H; Shi, Y; Zhai, J | 1 |
| Cai, M; Chen, D; Dilimulati, D; Gao, X; Qu, S; Shao, X; Sun, H; You, H; Zhang, M; Zhang, Y | 1 |
| Atkin, SL; Butler, AE; Moin, ASM; Sathyapalan, T | 2 |
| Demirpence, M; Girgin, EM; Karakoyun, I; Yilmaz Yasar, H | 1 |
| Kowalcze, K; Krysiak, R; Okopień, B | 2 |
| Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Bjekić-Macut, J; Bojanin, D; Djukić, T; Macut, D; Mastorakos, G; Mažibrada, I; Perović, S; Plavšić, L; Plješa-Ercegovac, M; Savić-Radojević, A; Simić, PD; Simić, T | 1 |
| Artenisio, AC; Benvenga, S; Borrielli, I; Bruno, LM; Giunta, L; La Marca, A; Pizzo, A; Stabile, G; Volpe, A | 1 |
| Bagir, GS; Bakiner, OS; Bozkirli, E; Cavlak, G; Ertorer, ME; Serinsoz, H | 1 |
| Colao, A; De Sio, I; Giallauria, F; Lombardi, G; Maresca, L; Orio, F; Palomba, S; Savastano, S; Vigorito, C; Vuolo, L | 1 |
| Naito, I; Ohno, N; Ohno, S; Saitoh, S; Terada, N; Zhou, H | 1 |
| del Rey Sánchez, JM; Escobar-Morreale, HF; Luque-Ramírez, M; Matíes, M; Mendieta-Azcona, C | 1 |
| Berdeli, A; Cetinkalp, S; Erdogan, M; Karadeniz, M; Ozgen, AG; Saygili, F; Tamsel, S; Yilmaz, C | 1 |
| Adonakis, G; Armeni, AK; Decavalas, G; Georgopoulos, NA; Karela, A; Markantes, G; Saltamavros, AD; Vervita, V | 1 |
| Baghaei, F; Holm, G; Janson, PO; Lönn, M; Mannerås-Holm, L; Olivecrona, G; Stener-Victorin, E | 1 |
| Andrade, CD; de Bittencourt, PI; Nácul, AP; Schwarz, P; Spritzer, PM | 1 |
| Alper, GE; Cağlayan, O; Erdoğan, M; Karadeniz, M; Saygili, F; Tamsel, S; Yilmaz, C; Zengi, A | 1 |
| Battaglia, C; Cianciosi, A; de Aloysio, D; Facchinetti, F; Mancini, F; Reggiani, GM | 1 |
| Abdelnoor, M; Andersen, P; Arnesen, H; Birkeland, K; Dale, PO; Løvik, A; Seljeflot, I | 1 |
| Dahlgren, E; Janson, PO; Johansson, S; Lapidus, L; Lindstedt, G; Tengborn, L | 1 |
| Atiomo, WU; Bates, SA; Condon, JE; Prentice, AG; Shaw, S; West, JH | 1 |
| Aulesa, C; de Zegher, F; Dunger, DB; Ibáñez, L; Ong, K; Potau, N | 1 |
4 trial(s) available for fibrinogen and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
Topics: Adiponectin; Adolescent; C-Reactive Protein; Female; Fibrinogen; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Menstrual Cycle; Menstruation Disturbances; Pioglitazone; Polycystic Ovary Syndrome; Thiazolidinediones; Young Adult | 2014 |
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Topics: Adult; Androgen Antagonists; Blood Coagulation; Blood Platelets; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Fibrinogen; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Obesity; Partial Thromboplastin Time; Polycystic Ovary Syndrome; Prothrombin; Smoking; Young Adult | 2009 |
Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
Topics: Adolescent; Adult; Blood Viscosity; Body Mass Index; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fibrinogen; Humans; Polycystic Ovary Syndrome; Triglycerides; Young Adult | 2011 |
Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
Topics: Adipocytes; Adult; Biomarkers; Blood Coagulation; Blood Pressure; Electroacupuncture; Exercise Therapy; Female; Fibrinogen; Fibrinolysis; Heart Rate; Humans; Insulin Resistance; Lipoprotein Lipase; Oxygen Consumption; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Prospective Studies; Subcutaneous Fat, Abdominal; Sweden; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2012 |
20 other study(ies) available for fibrinogen and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Predictive Factors for Recovery Time in Conceived Women Suffering From Moderate to Severe Ovarian Hyperstimulation Syndrome.
Topics: Albumins; Female; Fibrinogen; Humans; Hyperplasia; Male; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Pregnancy; Retrospective Studies; Sperm Injections, Intracytoplasmic | 2022 |
Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Body Mass Index; Case-Control Studies; China; Cholesterol, HDL; Female; Fibrinogen; Glycated Hemoglobin; Hormones; Humans; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Uric Acid | 2022 |
Components of the Complement Cascade Differ in Polycystic Ovary Syndrome.
Topics: CD55 Antigens; Cohort Studies; Complement C1q; Complement C3b; Complement Factor B; Complement Factor D; Complement Factor H; Cytokines; Female; Fibrinogen; Humans; Insulin Resistance; Mannose-Binding Lectin; Polycystic Ovary Syndrome; Properdin; Proteomics | 2022 |
Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity.
Topics: Aged; Body Mass Index; Cohort Studies; Female; Fibrinogen; Humans; Inflammation; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome | 2023 |
Galanin-like peptide and its correlation with androgen levels in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgens; Body Mass Index; C-Reactive Protein; Female; Fibrinogen; Follicle Stimulating Hormone; Galanin-Like Peptide; Humans; Insulin; Luteinizing Hormone; Middle Aged; Obesity; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2023 |
Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.
Topics: Androgens; Body Mass Index; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Female; Fibrinogen; Humans; Insulin; Insulin Resistance; Lisinopril; Polycystic Ovary Syndrome; Risk Factors; Siblings; Testosterone; Uric Acid | 2023 |
The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome.
Topics: Androgens; Atorvastatin; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Female; Fibrinogen; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Risk Factors; Siblings; Testosterone; Uric Acid | 2023 |
The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
Topics: Adult; Aged; Androgens; Anticholesteremic Agents; Atorvastatin; Blood Glucose; C-Reactive Protein; Cardiometabolic Risk Factors; Female; Fibrinogen; Homocysteine; Humans; Hydroxycholecalciferols; Insulin Resistance; Lipids; Male; Middle Aged; Polycystic Ovary Syndrome; Risk Factors; Testosterone; Uric Acid | 2021 |
The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome.
Topics: Adolescent; Anthropometry; Body Mass Index; C-Reactive Protein; Female; Fibrinogen; Humans; Insulin Resistance; Lipids; Polycystic Ovary Syndrome; Waist Circumference | 2018 |
Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes.
Topics: Adult; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin Resistance; Phenotype; Polycystic Ovary Syndrome; Risk Assessment; Triglycerides; Young Adult | 2016 |
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS).
Topics: Acute-Phase Proteins; Adult; C-Reactive Protein; Cardiovascular System; Female; Fibrinogen; Humans; Intra-Abdominal Fat; Leukocyte Count; Logistic Models; Motor Activity; Oxygen Consumption; Polycystic Ovary Syndrome; Respiratory System; Retrospective Studies; Ultrasonography | 2009 |
Permselectivity of blood follicle barriers in mouse ovaries of the mifepristone-induced polycystic ovary model revealed by in vivo cryotechnique.
Topics: Alpha-Globulins; Animals; Biomarkers; Blood Vessels; Capillary Permeability; Cryopreservation; Female; Fibrinogen; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mifepristone; Models, Animal; Ovary; Polycystic Ovary Syndrome; Regional Blood Flow; Serum Albumin; Staining and Labeling; Tissue Fixation | 2008 |
The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients.
Topics: 17-alpha-Hydroxyprogesterone; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; DNA; fas Receptor; Female; Fibrinogen; Genotype; Humans; Insulin; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Testosterone; Triglycerides | 2010 |
Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.
Topics: Adult; Androgens; Body Mass Index; Female; Fibrinogen; Hirsutism; Humans; Insulin Resistance; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Waist-Hip Ratio | 2007 |
Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances.
Topics: Adolescent; Adult; Biomarkers; C-Reactive Protein; Disulfides; Female; Fibrinogen; Humans; Insulin Resistance; Malondialdehyde; Nitric Oxide; Oxidative Stress; Polycystic Ovary Syndrome | 2008 |
Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
Topics: Adult; Androgens; Blood Flow Velocity; Brachial Artery; Case-Control Studies; Endothelin-1; Endothelium, Vascular; Female; Fibrinogen; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Menstruation; Overweight; Polycystic Ovary Syndrome; Progesterone; Vasodilation; Young Adult | 2009 |
Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Mass Index; Body Weight; C-Peptide; Diet, Reducing; Factor VII; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin; Insulin Resistance; Lipids; Obesity; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Tissue Plasminogen Activator | 1995 |
Hemostatic and metabolic variables in women with polycystic ovary syndrome.
Topics: Adult; Antigens; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Hypertension; Insulin; Menopause; Middle Aged; Plasminogen Inactivators; Polycystic Ovary Syndrome; Regression Analysis; Triglycerides; von Willebrand Factor | 1994 |
The plasminogen activator system in women with polycystic ovary syndrome.
Topics: Adult; alpha-2-Antiplasmin; Blood Coagulation Factors; Case-Control Studies; Female; Fibrinogen; Hormones; Humans; Phlebotomy; Plasminogen; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Tissue Plasminogen Activator | 1998 |
Plasminogen activator inhibitor-1 in girls with precocious pubarche: a premenarcheal marker for polycystic ovary syndrome?
Topics: Biomarkers; Birth Weight; Blood Glucose; Child; Cross-Sectional Studies; Female; Fibrinogen; Humans; Longitudinal Studies; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Puberty, Precocious; Risk Factors; Testosterone; Tissue Plasminogen Activator | 2002 |